Novartis has announced the
approval for pre-qualification of
its malaria treatment Coartem
80/480mg, opening up greater
access for patients.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 17 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jul 15
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.